Human herpesvirus 6: molecular biology and clinical features
- PMID: 12488560
- DOI: 10.1099/jmm.0.05074-0
Human herpesvirus 6: molecular biology and clinical features
Abstract
Human herpesvirus 6 (HHV-6) exists as distinct variants HHV-6A and HHV-6B. The complete genomes of HHV-6A and HHV-6B have been sequenced. HHV-6B contains 97 unique genes. CD46 is the cell receptor for HHV-6, explaining its broad tissue tropism but its restricted host-species range. HHV-6 utilizes a number of strategies to down-regulate the host immune response, including molecular mimicry by production of a functional chemokine and chemokine receptors. Immunosuppression is enhanced by depletion of CD4 T lymphocytes via direct infection of intra-thymic progenitors and by apoptosis induction. Infection is widespread in infants between 6 months and 2 years of age. A minority of infants develop roseola infantum, but undifferentiated febrile illness is more common. Reactivation from latency occurs in immunocompromised hosts. Organ-specific clinical syndromes occasionally result, but indirect effects including interactions with other viruses such as human immunodeficiency virus type 1 and human cytomegalovirus or graft dysfunction in transplant recipients may be more significant complications in this population. Recent advances in quantitative PCR are providing additional insights into the natural history of infection in paediatric populations and immunocompromised hosts.
Similar articles
-
Clinical impact of primary infection with roseoloviruses.Curr Opin Virol. 2014 Dec;9:91-6. doi: 10.1016/j.coviro.2014.09.013. Epub 2014 Oct 14. Curr Opin Virol. 2014. PMID: 25462439 Free PMC article. Review.
-
A Murine Herpesvirus Closely Related to Ubiquitous Human Herpesviruses Causes T-Cell Depletion.J Virol. 2017 Apr 13;91(9):e02463-16. doi: 10.1128/JVI.02463-16. Print 2017 May 1. J Virol. 2017. PMID: 28179532 Free PMC article.
-
Late-phase human herpesvirus 6B reactivation in hematopoietic stem cell transplant recipients.Transpl Infect Dis. 2018 Aug;20(4):e12916. doi: 10.1111/tid.12916. Epub 2018 Jun 13. Transpl Infect Dis. 2018. PMID: 29797616
-
Phenotypic and Functional Differences between Human Herpesvirus 6- and Human Cytomegalovirus-Specific T Cells.J Virol. 2019 Jun 14;93(13):e02321-18. doi: 10.1128/JVI.02321-18. Print 2019 Jul 1. J Virol. 2019. PMID: 30996090 Free PMC article.
-
Roseolovirus-associated encephalitis in immunocompetent and immunocompromised individuals.J Neurovirol. 2017 Feb;23(1):1-19. doi: 10.1007/s13365-016-0473-0. Epub 2016 Aug 18. J Neurovirol. 2017. PMID: 27538995 Free PMC article. Review.
Cited by
-
Monitoring of active human herpes virus 6 infection in Iranian patients with different subtypes of multiple sclerosis.J Pathog. 2013;2013:194932. doi: 10.1155/2013/194932. Epub 2013 Jan 22. J Pathog. 2013. PMID: 23431459 Free PMC article.
-
Detection of human herpesvirus-6 in adult central nervous system tumors: predominance of early and late viral antigens in glial tumors.J Neurooncol. 2009 Oct;95(1):49-60. doi: 10.1007/s11060-009-9908-2. Epub 2009 May 8. J Neurooncol. 2009. PMID: 19424665
-
Viral-associated lymphoid proliferations.Semin Diagn Pathol. 2013 May;30(2):130-6. doi: 10.1053/j.semdp.2012.08.009. Epub 2013 Mar 26. Semin Diagn Pathol. 2013. PMID: 23537914 Free PMC article. Review.
-
Recent progress of elucidating the mechanisms of drug hypersensitivity.Asia Pac Allergy. 2012 Jul;2(3):203-9. doi: 10.5415/apallergy.2012.2.3.203. Epub 2012 Jul 25. Asia Pac Allergy. 2012. PMID: 22872823 Free PMC article.
-
The Spontaneous Course of Human Herpesvirus 6 DNA-Associated Myocarditis and the Effect of Immunosuppressive Intervention.Viruses. 2022 Jan 31;14(2):299. doi: 10.3390/v14020299. Viruses. 2022. PMID: 35215893 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Research Materials
